Cash Flow Diamyd Medical AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Aug'25
Aug'24
Aug'23
Aug'22
Aug'21
Aug'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-169.00
-157.00
-111.00
-100.00
60.00
9.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
7.00
-1.00
17.00
-24.00
6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-169.00
-129.00
-110.00
-93.00
-109.00
16.00
Cash Flow from Investing Activities
17.00
-27.00
28.00
-76.00
132.00
4.00
Cash Flow from Financing Activities
316.00
142.00
86.00
142.00
56.00
0.00
Net Cash Inflow / Outflow
164.00
-14.00
7.00
-19.00
81.00
21.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
3.00
8.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Diamyd Medical AB
Figures in Million
consolidated Cash Flow Results
Change(SEK)
Change(%)
Profit Before Tax
-169.777
146.974
-315.00
-215.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-0.88
-13.487
13.00
93.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-169.683
150.135
-319.00
-213.02%
Cash Flow from Investing Activities
17.171
-0.472
17.00
3737.92%
Cash Flow from Financing Activities
316.322
103.863
213.00
204.56%
Net Cash Inflow / Outflow
164.427
248.784
-84.00
-33.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.617
-4.741
4.00
113.01%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Aug'25
YoY Growth in year ended Aug 2025 is -31.35% vs -16.42% in Aug 2024
Aug'25
Aug'24
Change(%)
Cash Flow from Operating Activities
-169.68
-129.18
-31.35%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
